First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure

被引:39
|
作者
Esmore, DS
Kaye, D
Salamonsen, R
Buckland, M
Rowland, M
Negri, J
Rowley, Y
Woodard, J
Begg, JR
Ayre, P
Rosenfeldt, FL
机构
[1] Alfred Hosp, Dept Cardiothorac Surg, Prahran, Vic 3181, Australia
[2] Alfred Hosp, Dept Cardiol, Prahran, Vic 3181, Australia
[3] Alfred Hosp, Dept Anaesthesia & Intens Care, Prahran, Vic 3181, Australia
[4] Ventracor Ltd, Chatswood, NSW, Australia
[5] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia
来源
关键词
D O I
10.1016/j.healun.2005.01.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The VentrAssist device left ventricular assist system, designed for permanent implantation, is a novel centrifugal pump with a hydrodynamically suspended rotor. The first human implant was into a 72-year-old man with New York Heart Association (NYHA) class IV heart failure due to idiopathic dilated cardiomyopathy. The implant and recovery were uneventful, and the patient survives at 17 months, is NYHA class 11, and lives at home. This device shows promise in end-stage. heart failure for permanent implantation and bridge to transplantation.
引用
收藏
页码:1150 / 1154
页数:5
相关论文
共 50 条
  • [31] Left ventricular assist device as destination therapy in cardiac end-stage dystrophinopathies: Midterm results
    Perri, Gianluigi
    Filippelli, Sergio
    Adorisio, Rachele
    Iacobelli, Roberta
    Iodice, Francesca
    Testa, Giuseppina
    Paglietti, Maria Giovanna
    D'Amario, Domenico
    Massetti, Massimo
    Amodeo, Antonio
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (03): : 669 - 674
  • [32] Implanting left ventricular assist device in end-stage heart failure with massive ventricular aneurysm
    Yao, Shaowen
    Qin, Yannv
    Yue, Jiarui
    Lu, Shichun
    ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3332 - 3334
  • [33] Preoperative risk factors for early mortality following use of left-ventricular assist device as destination therapy for end-stage heart failure
    Lietz, K
    Long, J
    Kfoury, AG
    Slaughter, MS
    Silver, MA
    Milano, CA
    Rogers, J
    Miller, LW
    CIRCULATION, 2005, 112 (17) : U391 - U391
  • [34] Destination therapy with a left ventricular assist device for end-stage heart failure patients. A single center ten-year experience
    Rorris, Filippos-Paschalis
    Antonopoulos, Constantine N.
    Koutsavli, Dimitra
    Psevdi, Aikaterini
    Margari, Zafeiria J.
    Tsamatsoulis, Michalis
    Samiotis, Ilias
    Argiriou, Michalis
    Charitos, Christos
    HELLENIC JOURNAL OF CARDIOLOGY, 2023, 69 : 61 - 63
  • [35] Cancer in End-Stage Heart Failure Patients Supported by Left Ventricular Assist Devices
    Loyaga-Rendon, Renzo Y.
    Inampudi, Chakradhari
    Tallaj, Jose A.
    Acharya, Deepak
    Pamboukian, Salpy V.
    ASAIO JOURNAL, 2014, 60 (05) : 609 - 612
  • [36] Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure
    Miller, P. Elliott
    Caraballo, Cesar
    Ravindra, Neal G.
    Mezzacappa, Catherine
    McCullough, Megan
    Gruen, Jadry
    Levin, Andrew
    Reinhardt, Samuel
    Ali, Ayyaz
    Desai, Nihar R.
    Ahmad, Tariq
    CIRCULATION-HEART FAILURE, 2019, 12 (11)
  • [37] Innovations in Ventricular Assist Devices for End-Stage Heart Failure
    Miller, Robert J. H.
    Teuteberg, Jeffrey J.
    Hunt, Sharon A.
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 33 - 44
  • [38] Outcome Through the Years of Left-Ventricular Assist Devices Therapy for End-Stage Heart Failure: A Review
    Tropea, Ilaria
    Cresce, Giovanni Domenico
    Sanesi, Valerio
    Salvador, Loris
    Zoni, Daniele
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [39] Advances in Continuous Flow Left Ventricular Assist Device Support for End-Stage Heart Failure A Therapy in Evolution
    Saeed, Omar
    Jorde, Ulrich P.
    CARDIOLOGY IN REVIEW, 2017, 25 (02) : 84 - 88
  • [40] The impact of patient selection on long-term outcomes of left-ventricular assist device implantation as destination therapy for end-stage heart failure
    Lietz, K
    Long, J
    Kfoury, AG
    Slaughter, MS
    Silver, MA
    Milano, CA
    Rogers, J
    Miller, LW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 75A - 75A